Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...
The definition and clinical use of common HBV serological markers are shown in Table 2. HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B.
Before the virus was identified ... Maine had the highest rate of new acute hepatitis C infections in the nation from 2020-22, the most recent years in which data is available, according to ...
GS-2121 is under clinical development by Gilead Sciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...
Prevents contamination of the patient and the environment (air, surfaces, equipment), protects the wearer from airborne infectious agents and protects against the risk of splashing biological fluids.